Strides Pharma Science Allots 7,500 Equity Shares Under ESOP 2016
Strides Pharma Science Ltd 路 Others (Uncategorized) 路 30 Oct 2026, 12:30 am
Strides Pharma Science Allots 7,500 Equity Shares Under ESOP 2016 Strides Pharma Science approved the allotment of 7,500 equity shares of face value Rs. 10 each on 29th Oct'26, pursuant to the exercise of stock options under the Strides ESOP 2016 Plan. The new shares rank pari passu with existing equity shares. Consequently, the company's paid-up equity share capital increased from Rs. 921,727,140 (92,172,714 shares) to Rs. 921,802,140 comprising 92,180,214 equity shares of Rs. 10 each.
Original exchange filing (PDF)
More announcements from Strides Pharma Science Ltd
- Transcript of Earnings Call pertaining of Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 02 Nov 2026
- Audio Recording of Earnings Call pertaining to unaudited Financial Results for the quarter and half year ended September 30, 2026 路 30 Oct 2026
- Appointment of Mr. Biren Gabhawala (DIN:03091772) as a Non-Executive Independent Director of the Company with effect from November 1, 2026. 路 30 Oct 2026
- Earnings presentation for the quarter and half year ended September 30, 2026. 路 30 Oct 2026
- Strides Delivers Strong Performance with Q2FY27 Revenue at Rs. 14.297m, Grew 17% YoY. Ex-US Markets Up 31% YoY; EBITDA Up 8% YoY to Rs. 2,509m, Crossing Rs. 2,500m in a Quarter for the First Time. 路 30 Oct 2026
- Financial Results for the quarter and half year ended Sept 30, 2026 路 30 Oct 2026
- Strides Pharma Science Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 30 Oct 2026
- Earnings Call to discuss the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2026 路 30 Oct 2026
